Intensive Hemodialysis and Health-related Quality of Life

Slides:



Advertisements
Similar presentations
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
Advertisements

Exam 2 Review. Example Information A researcher wants to know if using their flashcard program increases the number of items an individual can memorize.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effectiveness of Foot Orthoses to Treat Plantar Fasciitis:
Date of download: 11/12/2016 From: Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of DiseaseA Randomized,
Depression, Worry, and Psychosocial Functioning
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
The SPRINT Research Group
McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL
Intensive Hemodialysis, Treatment Complications and Tolerability
From: Case-Finding Instruments for Depression in Primary Care Settings
Intensive Hemodialysis, Treatment Complications and Tolerability
Copyright © 2003 American Medical Association. All rights reserved.
McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
Intensive Hemodialysis and Health-related Quality of Life
The Relationship Between Mental and Physical Health
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Intensive hemodialysis—keeping the faith
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Change in mean LVMI with erythropoietin alpha hemoglobin maintenance treatment and control/delayed treatment from baseline to 24 months End point Hemoglobin.
The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta-Analysis  Emmilia A. Dowlatshahi,
Susan P.Y. Wong, MD, Ann M. O'Hare, MD, MA 
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease Torres et al. Am J.
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Erratum Regarding “Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials” (Am.
Figure 1 Patient flow diagram
Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary.
Intensive hemodialysis—keeping the faith
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Intensive Hemodialysis and Health-Related Quality of Life
The risk of hospitalization and modality failure with home dialysis
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
What Do We Learn From an Equivalence Study Without Statistical Power?
Erratum Regarding “Ultrasound Monitoring to Detect Access Stenosis in Hemodialysis Patients: A Systematic Review” (Am J Kidney Dis. 2008;51(4): ) 
Volume 82, Issue 1, Pages (July 2012)
The Use of Life-Sustaining Procedures in the Last Month of Life Is Associated With More Depressive Symptoms in Surviving Spouses  Katherine A. Ornstein,
Volume 80, Issue 10, Pages (November 2011)
Recasting Kidney Failure as Cardiovascular Disease
Michael Copland, MD, Paul Komenda, MD, Eric D
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Volume 91, Issue 5, Pages (May 2017)
This Month in AJKD American Journal of Kidney Diseases
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial  Ramon Paniagua, Dante Amato, Edward Vonesh,
Volume 91, Issue 3, Pages (March 2017)
Prolonged Treatment with Transdermal Fentanyl in Neuropathic Pain
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1  Lyndsay S. Baines, John T. Joseph,
Volume 64, Issue 3, Pages (September 2003)
Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C) 
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial 
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
Intensive Hemodialysis and Potential Risks With Increasing Treatment
George L. Bakris, MD, John M. Burkart, MD, Eric D
Volume 75, Issue 5, Pages (March 2009)
Better Management of Volume with Intensive Hemodialysis
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.
Removal of Dabigatran by Hemodialysis
American Journal of Kidney Diseases
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia  David E. Leaf, David S. Goldfarb  Kidney.
This Month in AJKD American Journal of Kidney Diseases
In the Literature: Cognitive Impairment in Hemodialysis Patients
American Journal of Kidney Diseases
Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Dialysis Research and N-of-1 Trials: Made for Each Other?
Effect of randomized treatment on all renal events (top) and the composite of all renal events, macrovascular events, or all-cause mortality (bottom) according.
The cost of starting and maintaining a large home hemodialysis program
Changes in scores for the BDI (top graph), PSS (middle graph) and BAI (bottom graph) for high and low attenders. Changes in scores for the BDI (top graph),
The solid line represents the point estimate of the treatment ORs at various levels along the x-axis that ranges from the minimum to the maximum observed.
Presentation transcript:

Intensive Hemodialysis and Health-related Quality of Life Kraus MA, Fluck RJ, Weinhandl ED, Kansal S, Copland M, Komenda P, Finkelstein FO. Intensive Hemodialysis and Health-Related Quality of Life. American Journal of Kidney Diseases, Volume 68, Issue 5, S33 - S42. AdvancingDialysis.org

Intensive hemodialysis improved physical health-related quality of life in three randomized clinical trials, although the significance of individual effects varied.1,2,3 Chapter 4, Figure 1: Effects of intensive versus conventional hemodialysis on the physical-health composite score in the FHN Daily Trial,1 the FHN Nocturnal Trial,2 and the Canadian trial of nocturnal hemodialysis.3 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. 1FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300. doi:10.1056/NEJMoa1001593. 2Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091. doi:10.1038/ki.2011.213. 3Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int. 2009;75(5):542-549. doi:10.1038/ki.2008.639. +3.2 PCS +0.6 PCS +1.5 PCS AdvancingDialysis.org

Intensive hemodialysis also improved mental health-related quality of life in three randomized clinical trials, although the significance of individual effects varied.1,2,3 Chapter 4, Figure 2: Effects of intensive versus conventional hemodialysis on the physical-health composite score in the FHN Daily Trial,1 the FHN Nocturnal Trial,2 and the Canadian trial of nocturnal hemodialysis.3 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. 1Unruh ML, Larive B, Chertow GM, et al. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. Am J Kidney Dis Off J Natl Kidney Found. 2013;61(5):748-758. doi:10.1053/j.ajkd.2012.11.047. 2Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int. 2009;75(5):542-549. doi:10.1038/ki.2008.639. +3.5 MCS +3.7 MCS +2.5 MCS AdvancingDialysis.org

In the FHN trials, intensive hemodialysis decreased Beck Depression Inventory scores more so than conventional hemodialysis.1,2 Chapter 4, Figure 3: Effects of intensive versus conventional hemodialysis on the Beck Depression Inventory score in the FHN Daily Trial1 and the FHN Nocturnal Trial.2 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. -1.6 BDI 1FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300. doi:10.1056/NEJMoa1001593. 2Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011;80(10):1080-1091. doi:10.1038/ki.2011.213. -1.5 BDI AdvancingDialysis.org